There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

In October that year, the 36-year-old was diagnosed with juvenile Parkinson’s disease, a rare, intractable disease that robs patients of the ability to move. When she returned to her workplace ...

The study divulges essential insights on the market based on the Parkinson’s disease industry by type (juvenile parkinson disease, young-onset parkinson’s disease, idiopathic parkinson disease), by ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

“Genetic variants associated with larger brain volumes in key brain regions also increase the risk of Parkinson’s disease, while variants linked to smaller brain volumes in key regions are ...

On average, they survive for only two to five years after being diagnosed, according to the Centers for Disease Control and Prevention. Scientists at Northwestern and Case Western Reserve ...

We would like to thank the patient for allowing publication of Figure 3, for which his written consent was obtained. We would like to extend our sincere thanks to Dr O Suchowersky, Director of the ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...